ATE237629T1 - Rekombinanter virus der marek-krankheit, verfahren zur herstellung dieses viruses und diesen enthaltender impfstoff - Google Patents

Rekombinanter virus der marek-krankheit, verfahren zur herstellung dieses viruses und diesen enthaltender impfstoff

Info

Publication number
ATE237629T1
ATE237629T1 AT92111588T AT92111588T ATE237629T1 AT E237629 T1 ATE237629 T1 AT E237629T1 AT 92111588 T AT92111588 T AT 92111588T AT 92111588 T AT92111588 T AT 92111588T AT E237629 T1 ATE237629 T1 AT E237629T1
Authority
AT
Austria
Prior art keywords
disease virus
marek
same
viruse
producing
Prior art date
Application number
AT92111588T
Other languages
English (en)
Inventor
Masashi Sakaguchi
Michitaka Yamamoto
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE237629T1 publication Critical patent/ATE237629T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92111588T 1991-07-09 1992-07-08 Rekombinanter virus der marek-krankheit, verfahren zur herstellung dieses viruses und diesen enthaltender impfstoff ATE237629T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19570391 1991-07-09

Publications (1)

Publication Number Publication Date
ATE237629T1 true ATE237629T1 (de) 2003-05-15

Family

ID=16345577

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92111588T ATE237629T1 (de) 1991-07-09 1992-07-08 Rekombinanter virus der marek-krankheit, verfahren zur herstellung dieses viruses und diesen enthaltender impfstoff

Country Status (7)

Country Link
US (1) US5558867A (de)
EP (1) EP0522535B1 (de)
AT (1) ATE237629T1 (de)
AU (1) AU657144B2 (de)
CA (1) CA2073493C (de)
DE (1) DE69233004T2 (de)
ES (1) ES2195994T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09508005A (ja) * 1994-01-11 1997-08-19 コーネル リサーチ ファンデーション インコーポレイテッド 潜伏と腫瘍細胞発生の阻害によるマレク病の抑制
WO1995021255A1 (en) * 1994-02-07 1995-08-10 Cornell Research Foundation, Inc. Compositions useful in controlling marek's disease
JPH08116976A (ja) * 1994-10-20 1996-05-14 Chemo Sero Therapeut Res Inst 免疫用核酸調製物およびこれを用いた免疫方法
US6410311B1 (en) 1997-05-09 2002-06-25 Schering-Plough Veterinary Corporation Recombinant feline herpesvirus comprising a foreign DNA inserted into a region corresponding to a 3.0 kb EcoRI-SalI fragment of a feline herpesvirus genome
US6475770B1 (en) * 1997-06-10 2002-11-05 Pfizer, Inc. Processes for preparation of Marek's Disease using continuous mammalian cell lines
CN1099460C (zh) * 1997-12-26 2003-01-22 扬州大学 鸡马立克氏病病毒基因突变株及其应用
US6410222B1 (en) 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
EP1178111A1 (de) * 2000-08-03 2002-02-06 Lohmann Animal Health GmbH & Co. KG Impfung gegen Wirtzelle-assoziierte Herpesviren
CN119265146B (zh) * 2024-12-10 2025-08-12 中国农业科学院都市农业研究所 一种共同表达新城疫病毒f基因和传染性法氏囊病毒新型变异株vp2基因的重组马立克氏病病毒及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2779447B2 (ja) * 1988-03-20 1998-07-23 財団法人阪大微生物病研究会 弱毒マレック病ウイルス・ベクターを用いる組換え遺伝子作成法、及び該ウイルスの組換え体
JP2538367B2 (ja) * 1988-06-24 1996-09-25 ブリティッシュ・テクノロジー・グループ・リミテッド Ｆｏｗｌｐｏｘウィルスの非必須領域
JP2583115B2 (ja) * 1988-09-10 1997-02-19 財団法人化学及血清療法研究所 組換えマレック病ウイルスおよびその製法
JP3339854B2 (ja) * 1988-09-13 2002-10-28 メリアル ウイルスワクチン
ES2070997T3 (es) * 1989-12-04 1995-06-16 Akzo Nobel Nv Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
US5231023A (en) * 1990-07-30 1993-07-27 Akzo N.V. Recombinant Marek's disease virus
US6087127A (en) * 1990-08-24 2000-07-11 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE
US5138033A (en) * 1990-08-24 1992-08-11 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus glycoproteins GE
WO1993001353A1 (en) * 1991-07-02 1993-01-21 Eka Nobel Ab A process for the production of paper
US5403581A (en) * 1991-07-12 1995-04-04 Hoffmann-La Roche Inc. Coccidiosis vaccines

Also Published As

Publication number Publication date
EP0522535B1 (de) 2003-04-16
DE69233004T2 (de) 2004-01-22
ES2195994T3 (es) 2003-12-16
DE69233004D1 (de) 2003-05-22
AU657144B2 (en) 1995-03-02
EP0522535A1 (de) 1993-01-13
CA2073493C (en) 2003-05-27
US5558867A (en) 1996-09-24
AU1947892A (en) 1993-01-14
CA2073493A1 (en) 1993-01-10

Similar Documents

Publication Publication Date Title
JP3159446B2 (ja) 組換えアデノウイルス
DE69633581T2 (de) Alphavirus rna replikon-systeme
DE69535314T2 (de) Modifizierte Pflanzenviren als Vektore für Heterologe Peptide
HU230488B1 (hu) Simian adenovírus nukleinsav és aminosav-szekvencia, azt tartalmazó vektorok, és eljárások annak alkalmazására
US10717967B2 (en) Duck enteritis virus and the uses thereof
JPS60246317A (ja) 鳥レトロウイルス‐牛生長ホルモンｄｎａで形質転換されたカプセルに包含されたマウス細胞およびインビボにおけるｂｇｈの投与法
CA2276450C (en) A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent
EP3263129A1 (de) Entenenteritisvirus und verwendungen davon
CN110628730A (zh) 表达猪繁殖与呼吸综合征病毒gp蛋白的重组猪伪狂犬病病毒及应用
ATE237629T1 (de) Rekombinanter virus der marek-krankheit, verfahren zur herstellung dieses viruses und diesen enthaltender impfstoff
KR0181976B1 (ko) 미생물의 세포, 조직 또는 숙주 지향성을 변화시키는 방법, 이 방법으로 수득된 재조합 미생물, 및 의학 및 수의학 분야에서 이들을 사용하는 방법
WO2003039593A1 (en) Fowl adenovirus vaccine
DE68912478D1 (de) Rekombinantes Marek-Krankheitsvirus, Verfahren zu seiner Herstellung, und Vakzine.
JP3606870B2 (ja) 組換えトリアデノウイルスベクター
TWI224139B (en) Processes for preparation of Marek's disease virus using continuous avian cell lines
KR20020028884A (ko) 단백질 안정화 방법 및 이러한 안정화된 단백질의 제조에유용한 세포 계통의 제조방법
DE60028365T2 (de) Chimäre nukleinsäuren und polypeptide aus lyssavirus
JPH08501210A (ja) 遺伝子産物の持続的放出のための筋芽細胞の利用
US6475770B1 (en) Processes for preparation of Marek's Disease using continuous mammalian cell lines
McCahon Review of Achievements of Sector 2.1 Genetic Engineering of Virus and Cellular Genes Important in Animal Husbandry
TH25170A (th) รีคอมบิแนนท์วัคซีนของนกชนิดที่มีชีวิตโดยใช้เฮอร์ปีส์ไวรัสของนกเป็นเวกเตอร์
TH31920B (th) รีคอมบิแนนท์วัคซีนของนกชนิดที่มีชีวิตโดยใช้เฮอร์ปีส์ไวรัสของนกเป็นเวกเตอร์
JPH05244940A (ja) 組み換えアビポックスウィルス及びそれから成るワクチン
TH58175A3 (th) ขั้นตอนสำหรับการเตรียมไวรัสก่อโรคมาเร็คส์โดยการใช้เซลล์สายพันธุ์เอเวียนต่อเนื่อง
HK1032755A1 (zh) 重組的豬腺病毒載體

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties